Biomerica Inc (BMRA) Stock Price, Quote & News

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 645 2111

Fax: 949 553 1231

Website: www.biomerica.com

Address:

17571 Von Karman Avenue, Irvine, United States

prasan2015 Sep. 11 at 5:21 PM

$BMRA

0 · Reply

LeilaSheppard Sep. 9 at 5:54 PM

$BMRA Unitronix crypto treasury plus product build catalyst stack forming narrative heat meets tight float conditions ripe for vertical push 🚀

0 · Reply

Hurtadogoalkeeper Sep. 9 at 12:27 PM

$BMRA https://investors.biomerica.com/news/news-details/2025/Biomerica-Launches-AI-Backed-inFoods-IBS-Trigger-Food-Navigator-to-Support-Personalized-IBS-Therapy-and-Improve-Patient-Outcomes/default.aspx

0 · Reply

BigGreenCandle Sep. 9 at 12:12 PM

$BMRA Micro float. Nice volume influx.

0 · Reply

Stock_Catcher Sep. 9 at 12:09 PM

$BMRA hits

0 · Reply

NVDAMillionaire Sep. 8 at 2:14 PM

$BMRA Really good write-up that perfectly summarizes BMRA's present situation. So if you want to bring your BMRA knowledge up to date or just discover BMRA, this is required reading. https://beyondspx.com/quote/BMRA/analysis/biomerica-s-quest-for-growth-unlocking-value-through-niche-diagnostics-and-strategic-realignment-nasdaq-bmra

0 · Reply

nyg123 Sep. 5 at 2:26 AM

$BMRA hearing key players are leaving. Including CFO is interviewing.

1 · Reply

Bullliissh Sep. 4 at 5:59 PM

$BMRA DaBullRunner blocked me and I didn’t even call him out 😆😆😆… whatever that dude called man went to shit!! Or got delisted!

1 · Reply

richiehasfuntrading Sep. 4 at 5:40 PM

$BMRA 3rd Resistance Point 3.73 2nd Resistance Point 3.48 1st Resistance Point 3.16 Last Price 2.93 1st Support Level 2.59 2nd Support Level 2.34 3rd Support Level 2.02

0 · Reply

richiehasfuntrading Sep. 4 at 5:37 PM

$BMRA Selling at 3 may be back though you never know.

0 · Reply

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Sep 3, 2025, 8:19 AM EDT - 11 days ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Aug 29, 2025, 5:12 PM EDT - 15 days ago

Biomerica Reports Fiscal 2025 Year End Results

Aug 14, 2025, 8:19 AM EDT - 4 weeks ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

Jul 2, 2025, 8:08 AM EDT - 2 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jun 26, 2025, 8:19 AM EDT - 2 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 6, 2025, 9:30 AM EDT - 3 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 5, 2025, 8:19 AM EDT - 3 months ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

May 22, 2025, 8:19 AM EDT - 4 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 7, 2025, 8:19 AM EDT - 4 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

Apr 23, 2025, 8:19 AM EDT - 5 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 17, 2025, 8:19 AM EDT - 5 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 16, 2025, 9:00 AM EDT - 5 months ago

Biomerica Announces Reverse Stock Split

Feb 26, 2025, 8:19 AM EST - 7 months ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 19, 2025, 8:19 AM EST - 7 months ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Jan 16, 2025, 10:49 AM EST - 8 months ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 8:19 AM EST - 8 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 15, 2025, 8:19 AM EST - 8 months ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Nov 21, 2024, 8:19 AM EST - 10 months ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 7, 2024, 9:09 AM EST - 11 months ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Oct 30, 2024, 8:19 AM EDT - 11 months ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 16, 2024, 9:00 AM EDT - 11 months ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Sep 4, 2024, 8:19 AM EDT - 1 year ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results

Jul 1, 2024, 7:47 AM EDT - 1 year ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

May 13, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Apr 29, 2024, 8:19 AM EDT - 1 year ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 15, 2024, 7:47 AM EDT - 1 year ago

Biomerica provides update on inFoods® IBS expansion

Apr 12, 2024, 7:23 PM EDT - 1 year ago

Biomerica Reports Third Quarter 2024 Financial Results

Mar 28, 2024, 8:19 AM EDT - 1 year ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Feb 21, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Jan 23, 2024, 8:19 AM EST - 1 year ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 16, 2024, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter 2024 Financial Results

Dec 18, 2023, 7:47 AM EST - 1 year ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Nov 10, 2023, 8:19 AM EST - 2 years ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 8, 2023, 8:19 AM EST - 2 years ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Oct 13, 2023, 1:10 PM EDT - 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

Sep 26, 2023, 8:19 AM EDT - 2 years ago

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Aug 28, 2023, 8:19 AM EDT - 2 years ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Aug 25, 2023, 5:00 PM EDT - 2 years ago

Biomerica Reports Fiscal 2023 Year End Results

Aug 3, 2023, 8:19 AM EDT - 2 years ago

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Jun 21, 2023, 8:19 AM EDT - 2 years ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

May 18, 2023, 8:19 AM EDT - 2 years ago

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

Apr 17, 2023, 7:47 AM EDT - 2 years ago

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

Apr 14, 2023, 4:48 PM EDT - 2 years ago

Biomerica Reports Q3 Fiscal 2023 Results

Mar 8, 2023, 8:19 AM EST - 2 years ago

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

Mar 7, 2023, 4:39 PM EST - 2 years ago

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

Mar 3, 2023, 7:30 AM EST - 2 years ago

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

Mar 2, 2023, 5:15 PM EST - 2 years ago

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

prasan2015 Sep. 11 at 5:21 PM

$BMRA

0 · Reply

LeilaSheppard Sep. 9 at 5:54 PM

$BMRA Unitronix crypto treasury plus product build catalyst stack forming narrative heat meets tight float conditions ripe for vertical push 🚀

0 · Reply

Hurtadogoalkeeper Sep. 9 at 12:27 PM

0 · Reply

BigGreenCandle Sep. 9 at 12:12 PM

$BMRA Micro float. Nice volume influx.

0 · Reply

Stock_Catcher Sep. 9 at 12:09 PM

$BMRA hits

0 · Reply

NVDAMillionaire Sep. 8 at 2:14 PM

0 · Reply

nyg123 Sep. 5 at 2:26 AM

$BMRA hearing key players are leaving. Including CFO is interviewing.

1 · Reply

Bullliissh Sep. 4 at 5:59 PM

$BMRA DaBullRunner blocked me and I didn’t even call him out 😆😆😆… whatever that dude called man went to shit!! Or got delisted!

1 · Reply

richiehasfuntrading Sep. 4 at 5:40 PM

$BMRA 3rd Resistance Point 3.73 2nd Resistance Point 3.48 1st Resistance Point 3.16 Last Price 2.93 1st Support Level 2.59 2nd Support Level 2.34 3rd Support Level 2.02

0 · Reply

richiehasfuntrading Sep. 4 at 5:37 PM

$BMRA Selling at 3 may be back though you never know.

0 · Reply

richiehasfuntrading Sep. 4 at 5:33 PM

$BMRA Some people have too much time on their hands.

0 · Reply

DaBullRunner Sep. 4 at 5:16 PM

$BMRA anyone here have at least 100,000 shares? YOU IGNORE SMART MONEY YOU IGNORE BIG MONEY THIS SHOULDNT BE UNDER $3, $4, $5, ETC WATCH AND LEARN LIKE THIS👇

2 · Reply

DaBullRunner Sep. 4 at 5:15 PM

$BMRA 🚨LISTEN UP🚨 YOU IGNORE SMART MONEY YOU IGNORE BIG MONEY THIS SHOULDNT BE UNDER $3, $4, $5, ETC WATCH AND LEARN LIKE THIS👇

0 · Reply

DaBullRunner Sep. 4 at 5:09 PM

$BMRA there it goes… the BIG reversal $3+ coming Then $4 WATCH AND LEARN LIKE THIS👇

0 · Reply

DaBullRunner Sep. 4 at 5:05 PM

$INHD break $8 and thus could go nuclear $BMRA there it goes!!! 🚢📦📦📦📦📦📦📦🚨 WATCH AND LEARN LIKE THIS👇

0 · Reply

Bullliissh Sep. 4 at 5:04 PM

$BMRA just cause you spam the page all day doesn’t mean the stock will go up 🙃

0 · Reply

donutbreds Sep. 4 at 4:33 PM

$BMRA how high?

0 · Reply

DaBullRunner Sep. 4 at 4:27 PM

$SMX almost 40% in less than 30 min ALL profits going into $BMRA 🚢📦📦📦📦📦🚨 WATCH AND LEARN

0 · Reply

DaBullRunner Sep. 4 at 4:26 PM

$EH NHOD ASST not only called this in the .60’s but I buy what I call💰💰💰 Now I’m calling $BMRA before this breaks $3 then heads to $4+ 🚢📦📦📦📦📦📦📦🚨 And could eventually towards DD’s especially with that news WATCH AND LEARN LIKE👇

0 · Reply

DaBullRunner Sep. 4 at 4:22 PM

$SMX give me $2!!!!!!! $BMRA loading for the eventual reversal especially off that MOMSTER news

0 · Reply

DaBullRunner Sep. 4 at 4:12 PM

$DUO there it goes ASST not only called this in the .60’s but I buy what I call💰💰💰 Now I’m calling $BMRA before this breaks $3 then heads to $4+ 🚢📦📦📦📦📦📦📦🚨 And could eventually towards DD’s especially with that news WATCH AND LEARN LIKE👇

0 · Reply

DaBullRunner Sep. 4 at 4:07 PM

$ASST not only called this in the .60’s but I buy what I call👇💰💰💰✅ Now I’m calling $BMRA before this breaks $3 then heads to $4+ 🚢📦📦📦📦📦📦📦🚨 And could eventually towards DD’s especially with that news WATCH AND LEARN LIKE👇

0 · Reply

Market Cap	8.39M
Revenue (ttm)	5.31M
Net Income (ttm)	-4.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-93.60%
Debt to Equity Ratio	0.00

Volume	20,600
Avg Vol	1,017,720
Day's Range	N/A - N/A
Shares Out	2.82M
Stochastic %K	65%
Beta	0.35
Analysts	Strong Buy
Price Target	$13.00